News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
690
Sources here
17
Companies here
18
Search results Stored financial headlines

Active search

690 matching headlines

Ticker or company: PATMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

COMPASS Pathways (CMPS) Is Up 8.8% After Q2 Net Loss Surges To US$254 Million – Has The Bull Case Changed?

COMPASS Pathways reported a significant net loss of US$253.79 million in Q2 2026, a sharp increase from the previous year, with losses per share at US$1.88. This surge in expenses comes as the company remains pre-revenue, intensifying focus on its ability to fund the …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

COMPASS PATHWAYS ($CMPS) Releases Q2 2026 Earnings

This article first appeared on GuruFocus. Cash Position: $433 million in cash on hand as of June 30, 2026, expected to fund operations through launch and into 2028. Regulatory Milestone: Rolling NDA submission for COMP360 in treatment-resistant depression (TRD) underway; completion expected in the …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

COMPASS Pathways plc Q2 2026: Revenue $0 Net loss $253.8M, EPS $(1.88) — 10-Q Summary

COMPASS Pathways plc reported a net loss of $253.8M, or diluted loss per share of $(1.88), for Q2 2026, with no product revenue as it remains a clinical-stage company. The company achieved positive primary endpoints in Phase 3 trials for treatment-resistant depression and advanced …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Compass Pathways (Nasdaq: CMPS) posts $253.8M Q2 loss and builds COMP360 launch

Compass Pathways reported a Q2 2026 net loss of $253.8 million, largely due to a non-cash loss from warrant liabilities, compared to $38.4 million in Q2 2025. Despite the widened loss, the company is making significant progress with its COMP360 psilocybin treatment for treatment-resistant …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Data from two positive Phase 3 trials demonstrated rapid onset of effect and durable benefit through at least 6 months, further validating COMP360's potential to establish a new standard of care in TRD COMP360 has a highly differentiated clinical profile and is expected to …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PATTERSON UTI ENERGY INC 2026: Revenue $1.23B, Net income ($19.6M), EPS ($0.05) — 10-Q Summary

Patterson-UTI Energy Inc. reported its 2026 financial results, showing revenue of $1.23 billion, a net loss of ($19.6 million), and diluted EPS of ($0.05). These figures represent an improvement compared to the prior year quarter. The company saw increased revenue momentum, driven by stronger …

PTEN main company
Sharemaestro market context Trend signal active 52 weeks +105.2% PTEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amazon Partner Sets Up After 73% Surge, With Earnings On Watch

Pattern Group is finding support at its 50-day moving average as the stock carves a base that could offer a proper buy point at 29.80. Continue Reading

PTRN main company
Sharemaestro market context Trend signal active 48 weeks +37.2% · Next-week setup positive 73.3% PTRN stored weekly price path from 19 Sep 2025 to 14 Aug 2026

Compass Pathways Launches Proposed $150.0 Million Public Offering

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on mental health innovation, has announced a proposed public offering of $150.0 million in American Depositary Shares (ADSs) and pre-funded warrants. The company may also grant underwriters an option to purchase an additional $22.5 million …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patrick Industries Reports Mixed Quarter, Diversified Growth Offsets Rv Weakness

Patrick Industries reported essentially flat second-quarter net sales of $1.04 billion, with growth in its marine, powersports, and housing segments offsetting continued weakness in the recreational vehicle (RV) market. Despite a decline in operating income, net income increased significantly due to strategic diversification and …

PATK main company
Sharemaestro market context Price below Trend Line 52 weeks -24.6% · Next-week setup positive 56.1% PATK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally

Quick Read Palantir's Q2 revenue surged 93% to $1.94 billion, beating consensus, with U.S. commercial total contract value hitting a record $2.1 billion. PLTR rocketed 16% while AI and PATH caught zero sympathy bid, confirming this as a pure single-stock reaction to earnings. Palantir …

PATH main company
Sharemaestro market context Trend signal started 52 weeks +43.3% · Next-week setup negative 40.6% PATH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

Compass Pathways PLC (CMPS) saw muted stock gains despite announcing positive 26-week data from its COMP360 trial for treatment-resistant depression, which confirmed the drug's rapid onset and durability. Analysts maintained "Buy" or "Outperform" ratings, emphasizing the long-term market opportunity and the drug's clean safety …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PTEN Jumps 20% in a Month as Rig Pricing and Demand Strengthen

Patterson-UTI Energy, Inc. (PTEN) shares have increased by 20% over the past month due to improving U.S. drilling activity, equipment utilization, and service pricing. Despite this rally and strengthening operating conditions, the company still faces earnings and commodity risks, with projected net losses and …

PTEN main company
Sharemaestro market context Trend signal active 52 weeks +105.2% PTEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Compass Pathways PLC expected to post a loss of 40 cents a share - Earnings Preview

Compass Pathways PLC (CMPS) is projected to report a loss of 40 cents per share in its upcoming earnings announcement. This information is derived from a Refinitiv earnings preview. The full article can be accessed on TradingView, which aggregates news from various sources including …

CMPS main company
Sharemaestro market context Trend signal active 52 weeks +191.8% CMPS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patel Integrated Logistics: లాభాల్లో దూసుకుపోతున్న కంపెనీ.. రోడ్డు రవాణాలోకి రీ-ఎంట్రీ!

PATINTLOG main company
Sharemaestro market context Trend signal active 52 weeks -8.4% · Next-week setup negative 43.4% PATINTLOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patterson-UTI Energy Q2 Earnings & Revenues Beat Estimates

Patterson-UTI Energy (PTEN) reported strong Q2 2026 results, with adjusted earnings breaking even against an expected loss and total revenues exceeding estimates by 7%. This outperformance was driven by robust activity and pricing in its Completion Services segment and improved performance in Drilling Products …

PTEN main company
Sharemaestro market context Trend signal active 52 weeks +105.2% PTEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context